Chemical Structure : SY-1365
CAS No.: 1816989-16-8
Catalog No.: PC-72642Not For Human Use, Lab Use Only.
SY-1365 (Mevociclib, SY1365) is a potent, selective, covalent CDK7 inhibitor with Ki of 17.4 nM.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $278 | In stock | |
10 mg | $428 | In stock | |
25 mg | $728 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
SY-1365 (Mevociclib, SY1365) is a potent, selective, covalent CDK7 inhibitor with Ki of 17.4 nM.
SY-1365 displayed high selectivity against all other CDKs including CDK2,9 and 12 (IC50>2 uM), and 8 of 468 kinases including CDK7 were inhibited >90% in the kinome screen (DiscoverX KINOMEscan) at 1 uM.
SY-1365 dose- and time-dependently inhibited CDK7 substrates including RNAPII CTD phosphorylation at Ser2/5/7 sites and Thr160 of CDK2, caused massive cell death at 100 and 250 nM SY-1365 24 and 48 hours treatment in THP1, HCC70, and RPE-hTERT cell lines.
SY-1365 induced apoptosis in AML and TNBC cell lines but not in immortalized normal cell lines.
SY-1365 showed significant growth inhibition and cell killing in 386 human cell lines representing 26 cancer types in nanomolar range.
SY-1365 demonstrated substantial antitumor effects in multiple AML xenograft models as a single agent.
SY-1365-induced growth inhibition was enhanced in combination with the BCL2 inhibitor venetoclax.
SY-1365 is more potent, selective, and metabolically stable than THZ1.
M.Wt | 587.125 | |
Formula | C31H35ClN8O2 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO (5.9 mg/mL) |
|
Chemical Name/SMILES |
N-((1S,3R)-3-(5-chloro-4-(1H-indol-3-yl)pyrimidin-2-ylamino)-1-methylcyclohexyl)-5-((E)-4-(dimethylamino)but-2-enamido)picolinamide |
1. Hu S, et al. Cancer Res. 2019 Jul 1;79(13):3479-3491.
2. Webb BM, et al. J Biol Chem. 2021 Oct;297(4):101162.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright